Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (2,192,000)	$ (12,411,000)
Less: loss from discontinued operations, net of taxes of $0	(291,000)	(431,000)
Loss from continuing operations, net of taxes	(1,901,000)	(11,980,000)
Adjustments to reconcile loss from continuing operations to cash used in operating activities:
Depreciation and amortization	2,288,000	1,796,000
Amortization of debt discount	18,000	151,000
Deferred tax expense (benefit)	70,000	(3,130,000)
Provision for (recovery of) bad debt reserves	81,000	(351,000)
(Gain) loss on disposal of property and equipment	(1,000)	4,000
Impairment loss on tangible assets		1,816,000
Impairment loss on intangible assets		8,288,000
Issuance of common stock for services	103,000	116,000
Stock-based compensation	41,000	45,000
Changes in operating assets and liabilities of continuing operations
Restricted cash		35,000
Accounts receivable	246,000	(189,000)
Unbilled receivables	(845,000)	1,186,000
Prepaid expenses, inventories and other assets	37,000	1,789,000
Accounts payable, accrued expenses and unearned revenue	(881,000)	(1,041,000)
Cash used in continuing operations	(744,000)	(1,465,000)
Cash used in discontinued operations	(284,000)	(458,000)
Cash used in operating activities	(1,028,000)	(1,923,000)
Cash flows from investing activities:
Purchases of property and equipment	(116,000)	(28,000)
Proceeds from sale of property and equipment	7,000	2,000
Proceeds from/(payment to) finite risk sinking fund	5,880,000	(45,000)
Cash provided by (used in) investing activities of continuing operations	5,771,000	(71,000)
Cash provided by investing activities of dicontinued operations	34,000	51,000
Cash provided by (used in) investing activities	5,805,000	(20,000)
Cash flows from financing activities:
Repayments of revolving credit borrowings	(22,755,000)	(26,594,000)
Borrowing on revolving credit	18,952,000	29,131,000
Release of proceeds for stock subscription for Perma-Fix Medical S.A. previously held in escrow		64,000
Principal repayments of long term debt	(609,000)	(889,000)
Principal repayments of long term debt-related party		(750,000)
Payment of debt issuance costs		(71,000)
Cash (used in) provided by financing activities of continuing operations	(4,412,000)	891,000
Effect of exchange rate changes on cash	7,000	(4,000)
Increase (decrease) in cash	372,000	(1,056,000)
Cash at beginning of period	163,000	1,435,000
Cash at end of period	535,000	379,000
Supplemental disclosure:
Interest paid	194,000	204,000
Income taxes paid	$ 12,000	$ 25,000